))
Dermatology Edition: Top Headlines for Week of November 13, 2023
Manage episode 407442250 series 3560281
Sisällön tarjoaa Healio. Healio tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In this edition, dermatologists ‘uniquely positioned’ to aid human trafficking victims; FDA approves Cosentyx for hidradenitis suppurativa and more. Read the full coverage here:
Dermatologists ‘uniquely positioned’ to recognize, aid human trafficking victims
FDA approves Cosentyx as first IL-17A inhibitor for hidradenitis suppurativa
FDA approves Stelara biosimilar for treatment of psoriasis, multiple inflammatory diseases
RECELL system efficacious in vitiligo repigmentation
Isotretinoin efficacious in seborrheic dermatitis treatment
References:
Elbuluk N. Optimizing melanocyte cell transplant procedure for treatment of vitiligo. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.
Kourosh S. The role of dermatologic surgeons in advocating for those affected by human trafficking. Presented at: American Society for Dermatologic Surgery Annual Meeting; Nov 1-5, 2023; Chicago.
107 jaksoa
Jaa
